MODIFICATION TO SYNCHRON LX CLINICAL CHEMISTRY SYSTEMS (LX20 AND LX20 PRO)— 510(k) K014034
Substantially EquivalentBeckman Coulter, Inc.
FDA 510(k) clearance K014034 for MODIFICATION TO SYNCHRON LX CLINICAL CHEMISTRY SYSTEMS (LX20 AND LX20 PRO), Substantially Equivalent on 2001-12-18. Applicant: Beckman Coulter, Inc..
Clearance details
- Applicant
- Beckman Coulter, Inc.
- Product code
- Code JFL
- Advisory panel
- Clinical Chemistry
- Date received
- Decision date
- Decision
- Substantially Equivalent
- Clearance type
- Special
- Location
- Brea, CA, US
Data sourced from openFDA. This site is unofficial and independent of the FDA.